Leveraging single-domain antibodies and magnetic bead technology to improve manufacturing of T-cells for cell therapies

Autor:	Stav-Noraas, T. 2, Kjær, S. 2, Alfsnes, K. 2, Økern, G. 2, Bernstroem, K.E. 2, Gjolberg, D. 2, Klijs, E. 1, Wielders, C. 1, Adams, H. 1, de Rooij, J. 1, Almasbak, H. 2, Holt Herreng, T. 2, Hermans, P. 1, Sierkstra, L. 1, Amellem, O. 2
Zdroj:	In Cytotherapy May 2021 23(5) Supplement:S95-S95
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect